Grail Inc
GRAL86.360USD
+1.360+1.60%
收盘 10/28, 16:00（美东）报价延迟15分钟
3.11B总市值
亏损市盈率 TTM
关于 Grail Inc 公司
GRAIL, Inc.（前身为 GRAIL, LLC）是一家医疗保健公司，致力于拯救生命并改变早期癌症检测的范式。该公司专注于通过使用新一代测序、人口规模临床研究以及机器学习、软件和自动化来在早期阶段检测和识别多种致命癌症类型，从而减轻全球癌症负担。其基于靶向甲基化的平台可以支持筛查和精准肿瘤学的连续护理，包括有症状患者的多癌早期检测、风险分层、微小残留病检测、生物标志物亚型、治疗和复发监测。其产品包括 Galleri 和 Beyond。Galleri 测试是一种市售的筛查测试，用于早期检测多种类型的癌症，称为多癌早期检测 (MCED)。Galleri 筛查测试结果可以帮助指导医疗保健提供者诊断癌症的下一步措施。
Grail Inc简介
公司代码GRAL
公司名称Grail Inc
上市日期Jun 12, 2024
CEOMr. Robert (Bob) Ragusa
员工数量1000
证券类型Ordinary Share
年结日Jun 12
公司地址1525 O'brien Drive
城市MENLO PARK
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94025
电话18336942553
网址https://grail.com/
公司代码GRAL
上市日期Jun 12, 2024
CEOMr. Robert (Bob) Ragusa
Grail Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Aaron Freidin
Mr. Aaron Freidin
Chief Financial Officer
Chief Financial Officer
74.99K
-1.16%
Ms. Sarah Krevans
Ms. Sarah Krevans
Independent Director
Independent Director
68.19K
+9.79%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
12.32K
+3.57%
Mr. William J. (Bill) Chase
Mr. William J. (Bill) Chase
Independent Director
Independent Director
10.12K
+2.79%
Mr. Alex Dobbin
Mr. Alex Dobbin
IR Contact Officer
IR Contact Officer
--
--
Mr. Andy Partridge
Mr. Andy Partridge
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Robert (Bob) Ragusa
Mr. Robert (Bob) Ragusa
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Joshua (Josh) Ofman, M.D.
Mr. Joshua (Josh) Ofman, M.D.
President
President
--
--
Mr. Steve Mizell
Mr. Steve Mizell
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Aaron Freidin
Mr. Aaron Freidin
Chief Financial Officer
Chief Financial Officer
74.99K
-1.16%
Ms. Sarah Krevans
Ms. Sarah Krevans
Independent Director
Independent Director
68.19K
+9.79%
Mr. Gregory L. (Greg) Summe
Mr. Gregory L. (Greg) Summe
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
12.32K
+3.57%
Mr. William J. (Bill) Chase
Mr. William J. (Bill) Chase
Independent Director
Independent Director
10.12K
+2.79%
Mr. Alex Dobbin
Mr. Alex Dobbin
IR Contact Officer
IR Contact Officer
--
--
Mr. Andy Partridge
Mr. Andy Partridge
Chief Commercial Officer
Chief Commercial Officer
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
业务USD
名称
营收
占比
Screening
34.38M
96.72%
Development Services
1.17M
3.28%
地区USD
名称
营收
占比
United States
34.21M
96.24%
International
1.34M
3.76%
业务
地区
业务USD
名称
营收
占比
Screening
34.38M
96.72%
Development Services
1.17M
3.28%
股东统计
更新时间: 10月17日 周五
更新时间: 10月17日 周五
持股股东
股东类型
持股股东
持股股东
占比
Illumina Inc
12.49%
BlackRock Institutional Trust Company, N.A.
5.78%
PRIMECAP Management Company
5.70%
The Vanguard Group, Inc.
5.26%
CRCM L.P.
5.00%
其他
65.77%
持股股东
持股股东
占比
Illumina Inc
12.49%
BlackRock Institutional Trust Company, N.A.
5.78%
PRIMECAP Management Company
5.70%
The Vanguard Group, Inc.
5.26%
CRCM L.P.
5.00%
其他
65.77%
股东类型
持股股东
占比
Investment Advisor
26.94%
Investment Advisor/Hedge Fund
24.96%
Hedge Fund
13.20%
Corporation
12.49%
Research Firm
2.58%
Individual Investor
1.31%
Bank and Trust
0.51%
Pension Fund
0.33%
Family Office
0.18%
其他
17.51%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
919
24.74M
68.62%
-5.55M
2025Q2
874
30.08M
83.61%
-1.68M
2025Q1
859
29.51M
82.19%
-2.62M
2024Q4
810
31.24M
92.16%
+4.27M
2024Q3
748
27.13M
81.56%
+4.49M
2024Q2
646
27.14M
86.18%
+27.14M
2024Q1
2
135.00
0.00%
+135.00
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Illumina Inc
4.50M
12.49%
+4.50M
--
Jun 30, 2024
BlackRock Institutional Trust Company, N.A.
2.09M
5.78%
+969.56K
+86.91%
Jun 30, 2025
PRIMECAP Management Company
2.05M
5.7%
+2.71K
+0.13%
Jun 30, 2025
The Vanguard Group, Inc.
1.90M
5.26%
+402.62K
+26.97%
Jun 30, 2025
CRCM L.P.
1.84M
5.11%
-1.80M
-49.45%
Sep 30, 2025
Baker Bros. Advisors LP
1.63M
4.52%
--
--
Jun 30, 2025
AQR Capital Management, LLC
1.33M
3.69%
-6.55K
-0.49%
Jun 30, 2025
State Street Investment Management (US)
1.25M
3.46%
-20.25K
-1.60%
Jun 30, 2025
Arbiter Partners Capital Management, LLC
1.04M
2.88%
+12.86K
+1.25%
Jun 30, 2025
Sessa Capital
786.14K
2.18%
-721.93K
-47.87%
Jun 30, 2025
查看更多
持股ETF
更新时间: 10月6日 周一
更新时间: 10月6日 周一
机构名称
占比
Invesco Dorsey Wright Healthcare Momentum ETF
2.11%
ROBO Global Healthcare Technology & Innovation ETF
0.96%
Franklin Genomic Advancements ETF
0.65%
SPDR S&P Biotech ETF
0.33%
Invesco Dorsey Wright SmallCap Momentum ETF
0.27%
Invesco Russell 2000 Dynamic Multifactor ETF
0.25%
Direxion Daily S&P Biotech Bull 3X Shares
0.2%
ProShares Ultra Nasdaq Biotechnology
0.12%
Invesco Nasdaq Biotechnology ETF
0.12%
Vanguard US Momentum Factor ETF
0.1%
查看更多
Invesco Dorsey Wright Healthcare Momentum ETF
占比2.11%
ROBO Global Healthcare Technology & Innovation ETF
占比0.96%
Franklin Genomic Advancements ETF
占比0.65%
SPDR S&P Biotech ETF
占比0.33%
Invesco Dorsey Wright SmallCap Momentum ETF
占比0.27%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.25%
Direxion Daily S&P Biotech Bull 3X Shares
占比0.2%
ProShares Ultra Nasdaq Biotechnology
占比0.12%
Invesco Nasdaq Biotechnology ETF
占比0.12%
Vanguard US Momentum Factor ETF
占比0.1%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
